Shopping Cart
Remove All
Your shopping cart is currently empty
VNRX-9945 is a potent and orally active HBV capsid assembly modulator (CAM), exhibiting an EC50 value of 2.6 nM. It demonstrates excellent and broad-spectrum antiviral activity against multiple HBV genotypes in vitro, with favorable pharmacokinetic properties across various species. Additionally, VNRX-9945 shows significant antiviral efficacy in the AAV-HBV infected mouse model.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | 10-14 weeks | 10-14 weeks | |
| 50 mg | Inquiry | 10-14 weeks | 10-14 weeks |
| Description | VNRX-9945 is a potent and orally active HBV capsid assembly modulator (CAM), exhibiting an EC50 value of 2.6 nM. It demonstrates excellent and broad-spectrum antiviral activity against multiple HBV genotypes in vitro, with favorable pharmacokinetic properties across various species. Additionally, VNRX-9945 shows significant antiviral efficacy in the AAV-HBV infected mouse model. |
| In vitro | VNRX-9945 (Compound 12) exhibits potent antiviral activity against all HBV genotypes (A-H), with EC50 values ranging from 3 to 31 nM. |
| In vivo | Administered orally at doses ranging from 10 to 100 mg/kg twice daily for 8 weeks, VNRX-9945 demonstrated significant antiviral efficacy in a mouse model of adenovirus-associated hepatitis B virus (AAV-HBV) infection. |
| Molecular Weight | 429.48 |
| Formula | C23H28FN3O4 |
| Cas No. | 2396680-45-6 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.